Pharma/Life Sciences: Corporate | Europe

Alain Decombe maintains an eminent reputation for his advice on corporate transactions in the life sciences sector. He is adept at assisting with cross-border mandates.

Emmanuelle Trombe is widely recognised as a leading corporate practitioner in the pharmaceutical and life sciences sectors, with outstanding expertise in acquisitions, financing rounds and licensing agreements.

Jean-Marc Grosperrin boasts a leading corporate practice, advising pharmaceutical companies on commercial agreements and acquisitions.

Emmanuelle Porte of Bird & Bird handles a range of corporate matters in the pharmaceutical sector, including acquisitions and fundraisings.

Gilles Bigot of Winston & Strawn boasts longstanding experience advising investment funds and corporates on transactional matters, including primary LBOs.

Renaud Bonnet is highly recognised for assisting technology and life sciences companies with a range of corporate transactions, including financing rounds and initial public offerings.

Anne-Charlotte Rivière enters the rankings this year on the back of excellent market recognition. She advises clients on corporate matters in the life science space, offering notable experience in venture capital and M&A transactions.

Anthony Paronneau boasts experience in M&A transactions and licensing matters. He is highly sought after by biotech startups.

Sonia de Kondserovsky of DLA Piper LLP assists pharmaceutical companies with cross-border acquisitions and investments.

Up-and-coming partner Anne-France Moreau joins the table thanks to her experience handling M&A mandates in the pharma sector, including private equity transactions.